Osteointegration
is one of the most important factors for implant
success. Several biomolecules have been used as part of drug delivery
systems to improve implant integration into the surrounding bone tissue.
Chemically modified mRNA (cmRNA) is a new form of therapeutic that
has been used to induce bone healing. Combined with biomaterials,
cmRNA can be used to develop transcript-activated matrices for local
protein production with osteoinductive potential. In this study, we
aimed to utilize this technology to create bone morphogenetic protein
2 (BMP2) transcript-activated coatings for titanium (Ti) implants.
Therefore, different coating methodologies as well as cmRNA incorporation
strategies were evaluated. Three different biocompatible biomaterials
were used for the coating of Ti, namely, poly-
d
,
l
-lactic acid (PDLLA), fibrin, and fibrinogen. cmRNA-coated Ti disks
were assayed for transfection efficiency, cmRNA release, cell viability
and proliferation, and osteogenic activity
in vitro
. We found that cmRNA release was significantly delayed in Ti surfaces
previously coated with biomaterials. Consequently, the transfection
efficiency was greatly improved. PDLLA coating improved the transfection
efficiency in a concentration-dependent manner. Lower PDLLA concentration
used for the coating of Ti resulted in higher transfection efficiency.
Fibrin and fibrinogen coatings showed even higher transfection efficiencies
compared to all PDLLA concentrations. In those disks, not only the
expression was up to 24-fold higher but also the peak of maximal expression
was delayed from 24 h to 5 days, and the duration of expression was
also extended until 7 days post-transfection. For fibrin, higher transfection
efficiencies were obtained in the coatings with the lowest thrombin
amounts. Accordingly, fibrinogen coatings gave the best results in
terms of cmRNA transfection. All biomaterial-coated Ti surfaces showed
improved cell viability and proliferation, though this was more noticeable
in the fibrinogen-coated disks. The latter was also the only coating
to support significant amounts of BMP2 produced by C2C12 cells
in vitro
. Osteogenesis was confirmed using BMP2 cmRNA fibrinogen-coated
Ti disks, and it was dependent of the cmRNA amount present. Alkaline
phosphatase (ALP) activity of C2C12 increased when using fibrinogen
coatings containing 250 ng of cmRNA or more. Similarly, mineralization
was also observed that increased with increasing cmRNA concentration.
Overall, our results support fibrinogen as an optimal material to
deliver cmRNA from titanium-coated surfaces.